On May 3, 2024, the registrant registered $400,000,000 of shares of its Common stock (the “
Prior Unsold Securities
”) pursuant to Supplement No. 3 (“
Supplement No.
3
”) to the prospectus supplement dated November 4, 2021, as supplemented by supplement no. 1 dated February 25, 2022 and supplement no 2. dated November 3, 2023 (collectively, the “
Prior Prospectus Supplement
”) to its Registration Statement on Form
S-3
(File
No. 333-260758),
which was filed with the Securities and Exchange Commission (the “
SEC
”) and became automatically effective on November 4, 2021 (the “
Prior Registration Statement
”), relating to the registrant’s
program pursuant to the Sales Agreement, none of which was sold under the Prior Prospectus Supplement and the Prior Registration Statement. In connection with the filing of Supplement No. 3, the registrant made a contemporaneous fee payment in the amount of $59,040.00 related to the Prior Unsold Securities. Pursuant to Rule 415(a)(6) under the Securities Act, this Prospectus Supplement carries forward the Prior Unsold Securities, and the offering of the Prior Unsold Securities under the Prior Registration Statement was deemed terminated as of the effectiveness of the Registration Statement. Pursuant to Rule 457(p) under the Securities Act, the entire $59,040.00 of the filing fee previously paid relating to the Prior Unsold Securities is being carried over to partially offset the $61,240.00 registration fee due for this offering.